Intuitive (ISRG) - EV/EBITDA Multiple

Intuitive Corp - graphic logo of issuer ISRG

Intuitive Surgical generates revenue through the sale of robotic microsurgery systems and the recurring sale of consumables. The high cost of implementing Da Vinci and the dependence of clinics on service create a stable cash flow. Scaling intelligent motion automation strengthens the position of ISRG. The historical EV/EBITDA value on GURU.Markets visualizes the company's market value, where the 34.30 metric reflects the current business valuation dynamics.

ISRG Intuitive Surgical Inc: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/10/2026

Analytical breakdowns for intuitive.com (ISRG)

- stock price and consensus target price:
Stock Quotes Intuitive Surgical Inc|ISRG - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Intuitive Corp|ISRG - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Intuitive Surgical|ISRG - Accounting Capitalization|Market Value to Book Value Ratio intuitive.com|ISRG - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Equity Ratio Intuitive Surgical|ISRG - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Intuitive|ISRG - Aggregate Debt Obligations|Debt to Book Value Intuitive Corp|ISRG - Company Long-Term Debts|Company Short-Term Debt Intuitive Surgical|Quick Ratio intuitive.com
- business earnings and investment ratios data:
ISRG - Company Net Income|Expected Profit Intuitive Surgical|ISRG - Price to Earnings Multiple|Projected Price to Earnings Intuitive Surgical|ISRG - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Intuitive Corp|ISRG - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Intuitive Surgical|ISRG - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months intuitive.com|ISRG - Earnings per share growth this year|Expected earnings per share growth for next year Intuitive Surgical
Summary company analysis:Intuitive Surgical Inc (ISRG)
Manufactured products of Intuitive

This indicator compares the total enterprise value with its operating profit before depreciation and amortization. Investors utilize the EV/EBITDA metric, including depreciation and debt, to determine an asset's fair value and identify overvalued zones. Low values on the chart signal that the business is undervalued. For Intuitive Surgical (ISRG), this metric confirms the effective management of its monopoly position and the development of its surgical technology ecosystem.

Competitors of Intuitive Surgical

Danaher Corp - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation BDX|STERIS plc - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio westpharma.com WST|Baxter (BAX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MASI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stevanato|Teleflex Corp (TFX) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MMSI (Merit Medical Systems)|Enterprise Value to Operating Income Before Depreciation Ratio NVST|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ICU Medical ICUI|Business Value to Operating Income Before Depreciation XRAY|LMAT: Enterprise Value to EBITDA Ratio|ATRC - EV/EBITDA Multiple|STAAR Surgical Company (STAA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ChromaDex|ZIMV (ZimVie) - EV/EBITDA Multiple|Company Value to EBITDA AngioDynamics Inc ANGO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cerus Corp (CERS)|Teknova Inc - Enterprise Value to Operating Income Before Depreciation|Monogram Technologies - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio STSS (Sharps Technology Inc)|INFU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Utah Medical Products Inc. UTMD|KRMD: EV/EBITDA Multiple|NYXH - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Microbot Medical Inc.|Enterprise Value to Operating Income Before Depreciation PDEX (pro-dex.com)|Enterprise Value to EBITDA Ratio ZTEK (Zentek)|Enterprise Value to Operating Income Before Depreciation Ratio ELUT|Milestone Scientific Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple NEXGEL Inc NXGL|Retractable Tech - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Harvard Bioscience Inc. HBIO|FEMY (Femasys) - Enterprise Value to EBITDA Ratio|MHUA: Enterprise Value to Operating Income Before Depreciation Ratio|POAI (Predictive Oncology Inc) - EV/EBITDA Multiple|Callan JMB Corp (CJMB) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ATRI (Atrion Corporation)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NURO (neurometrix.com)